RecruitingNot Applicable

Virtual Physical Activity Seated Exercise - Phase 2

Canada100 participantsStarted 2023-10-11

Plain-language summary

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment. Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Participants must meet the following inclusion criteria: * Adult (as defined by Province) * Chronic stroke (more than 6 months post-stroke) * Ability to stand up from a chair * Mobility impairment of lower extremity (requires a walking aid, with or without close supervision) * Able to safely engage in exercise and tolerate 60 minutes of exercises * Able to communicate in English * Have access to a tablet, computer, or laptop with internet and email access Exclusion Criteria: Participants will be excluded if they meet any of the following criteria: * Participating in formal exercise or rehabilitation activities * Participating in \> 30 minutes/day of physical activity (moderate intensity) * Participating in another study that may affect outcomes to this study * Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software * A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer) * Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

30 Second Sit-to-Stand

Timeframe: Immediately post-intervention (following 10-week trial)

Trial details

NCT IDNCT05724823

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

Contact for this trial

Chihya Hung, MScPT

1-604-714-4117 chihya.hung@ubc.ca

View on ClinicalTrials.gov More Stroke trials